- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Caris Life Sciences Inc (CAI)
Track today's live Caris Life Sciences (CAI) share price, performance and key data on this page with our current NASDAQ:CAI stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Caris Life Sciences share price on the NASDAQ exchange. Use the dropdown to switch exchange for the CAI share price, head to our technical summary section, which provides analysis on Caris Life Sciences share price buy/sell indicators using real-time data (or discuss the Caris Life Sciences (CAI) stock price today with other investors in the Caris Life Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CAI share price (ISIN: US1421521071) to enhance your trading decisions with our free investment tools and resources.
What Is the Caris Life Sciences Inc Share Price Today?
The Caris Life Sciences share price today is 16.49.
What Is the Stock Symbol for Caris Life Sciences Inc
The stock symbol (or 'ticker') for Caris Life Sciences Inc is "CAI."
What Stock Exchange Does Caris Life Sciences Inc Trade On?
Caris Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Caris Life Sciences Inc a Good Stock to Buy?
Determining whether Caris Life Sciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CAI share price (ISIN: US1421521071) to enhance your trading decisions with our free investment tools and resources.
What Is the Caris Life Sciences Inc Share Price Today?
The Caris Life Sciences share price today is 16.49.
What Is the Stock Symbol for Caris Life Sciences Inc
The stock symbol (or 'ticker') for Caris Life Sciences Inc is "CAI."
What Stock Exchange Does Caris Life Sciences Inc Trade On?
Caris Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Caris Life Sciences Inc a Good Stock to Buy?
Determining whether Caris Life Sciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.02
16.74
52 wk Range
14.19
42.50
CAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.0216.74
52 wk Range
14.1942.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CAI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
27.00
Upside
+63.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
10 Buy
3 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 27.00
(+63.74% Upside)
Caris Life Sciences Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue surged 79% YoY to $216M, driven by 85% growth in molecular profiling services; gross margin improved to 65% from 47%.
- EPS of $0 beat forecast of -$0.12 loss by 100%; posted fourth consecutive quarter of positive adjusted EBITDA at $26M with $23.5M free cash flow.
- Stock plunged 15.58% after-hours to $16.15, down 46% YTD and trading near 52-week low despite strong earnings performance.
- Launched Caris ChromoSeq and MI Clarity products; successfully refinanced debt extending maturity to 2031 to support growth initiatives.
- Guidance projects Q3 2026 revenue of $240.14M with EPS of $0.01; Q4 EPS forecast at $0.04 as company expands precision oncology market presence.
Last Updated: 14/05/2026, 11:18
Read Full TranscriptEarnings
Latest Release
07/05/2026
EPS / Forecast
-- / -0.12
Revenue / Forecast
216.2M / --
Compare CAI to Peers and Sector
Metrics to compare | CAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.3x | −47.7x | −0.4x | |
PEG Ratio | −0.14 | −1.12 | 0.00 | |
Price/Book | 7.9x | 2.1x | 2.6x | |
Price / LTM Sales | 5.1x | 12.4x | 3.0x | |
Upside (Analyst Target) | 63.7% | 2.9% | 50.8% | |
Fair Value Upside | Unlock | −31.7% | 9.4% | Unlock |
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company’s molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Caris Life Sciences (NASDAQ: CAI) Share Price Today?
The Caris Life Sciences stock price today is 16.49 USD.
What Stock Exchange Does Caris Life Sciences (CAI) Trade On?
Caris Life Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Caris Life Sciences?
The stock symbol (also called a 'ticker') for Caris Life Sciences is "CAI."
What Is the Current Caris Life Sciences Market Capitalisation?
As of today, Caris Life Sciences (NASDAQ: CAI) market cap is 4.66B USD.
What Is Caris Life Sciences's (CAI) Earnings Per Share (TTM)?
The Caris Life Sciences EPS is currently -1.80 (Trailing Twelve Months).
When Is the Next Caris Life Sciences Earnings Date?
Caris Life Sciences's next earnings report will be released on 05/08/2026.
Is CAI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Caris Life Sciences moving averages and other technical indicators, the daily buy/sell signal for CAI stock is Strong Sell.
How Many Times Has Caris Life Sciences Stock Split?
Caris Life Sciences has split 0 times. (See the CAI stock split history page for full effective split date and price information.)
How Many Employees Does Caris Life Sciences Have?
Caris Life Sciences has 1846 employees, based on their latest Companies House report.
What is the current trading status of Caris Life Sciences (NASDAQ: CAI)?
As of 18/07/2026, Caris Life Sciences (CAI) is trading at a share price of 16.49 USD, with a previous close of 16.48 USD. The stock has fluctuated within a day range of 16.02 USD to 16.74 USD, while its 52-week range spans from 14.19 USD to 42.50 USD.
What Is Caris Life Sciences (CAI) Price Target According to Analysts?
The average 12-month price target for Caris Life Sciences is 27.00 USD, with a high estimate of 36 USD and a low estimate of 21 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +63.74% Upside potential.
What Is the CAI Premarket Price?
CAI's last pre-market stock price is 16.17 USD. The pre-market share volume is 3,930.00, and the stock has decreased by -0.31, or -1.88%.
What Is the CAI After Hours Price?
CAI's last after hours stock price is 16.81 USD, the stock has decreased by 0.32, or 1.94%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.